Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk.
Phase of Trial: Phase III
Latest Information Update: 09 May 2013
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Olive oil
- Indications Atherosclerosis; Cardiovascular disorders
- Focus Therapeutic Use
- 09 May 2013 Results published in the New England Journal of Medicine.
- 17 Jan 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00317707).
- 17 Jan 2012 Official Title amended as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History